Fine-tunes the activity of individual genes via an adaptable technology
The technology is potentially useful in biosensors, gene therapies targeted to specific types of cells, and the development of new antibacterial, antifungal, and anticancer treatments.
Develops photonic technologies that use targeted nanomaterials to detect, monitor, and treat breast and gynecologic cancers painlessly, and at a fraction of the cost of conventional approaches.
Slashed the cost of producing a DNA chip from hundreds of dollars to a few dollars by combining microfluidics, computer control, and novel electrochemistry.
Devised a way to remove kidney stones more cost effectively and less invasively by taking advantage of the ureters tendency to dilate around foreign objects.
Helped public-health officials control epidemics of walking pneumonia and SARS with sophisticated mathematical models that predict how a disease will spread through networks of human interactions.
Facilitated noninvasive optical imaging of proteins and other molecules in the body, which could lead to ultraprecise diagnosis of cancer and other diseases.
Models how individual cells in tissues migrate, multiply, and develop during processes such as blood vessel growth. The models should aid tissue engineering and drug development.
Discovered an enzyme that could enable environmentally benign production of fluorine-containing compounds such as Teflon and Prozac, which are now made via noxious chemical processes.
Came up with the first method that allows researchers to pattern proteins and cells directly onto glass or plastic surfaces or within microfluidic channels without complicated preparation.
Technology Review's Emerging Technologies Conference at MIT brings together world-renowned innovators and leaders to discuss the technological innovations destined to better our lives and fuel economic growth.
Massachusetts Institute of Technology
Comments